Literature DB >> 8846394

Calcitonin gene related peptide released from dural nerve fibers mediates increase of meningeal blood flow in the rat.

K Messlinger1, U Hanesch, M Kurosawa, M Pawlak, R F Schmidt.   

Abstract

The parietal dura mater encephali of the rat was shown by immunohistochemistry to be densely innervated by calcitonin gene related peptide (CGRP) immunoreactive nerve fibers spreading around the medial meningeal artery and its branches. Electrical stimulation of the dural surface (10-20 V, 5-10 Hz, 10-30 min) caused a depletion of CGRP-immunopositive fibers, suggesting a release of CGRP. The dural blood flow around branches of the medial meningeal artery was also monitored with a laser Doppler flowmeter. Short periods (30 s) of electrical stimulation with parameters that presumably released CGRP form nerve fibers caused a repeatable and constant increase of the blood flow for 1-2 min. This evoked increase could dose dependently be inhibited by topical application of the CGRP antagonist hCGRP8-37. Accordingly, administration of hCGRP increased the basal blood flow. We conclude that stimulation of trigeminal afferents innervating the dura mater releases CGRP from peptidergic afferent terminals, thereby causing vasodilatation and increasing the meningeal blood flow, an important element of neurogenic inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8846394     DOI: 10.1139/y95-143

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  22 in total

1.  Inhibition of stimulated meningeal blood flow by a calcitonin gene-related peptide binding mirror-image RNA oligonucleotide.

Authors:  Thomas Denekas; Markus Tröltzsch; Axel Vater; Sven Klussmann; Karl Messlinger
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  TRPA1 receptors mediate environmental irritant-induced meningeal vasodilatation.

Authors:  Phillip Edward Kunkler; Carrie Jo Ballard; Gerry Stephen Oxford; Joyce Harts Hurley
Journal:  Pain       Date:  2010-11-13       Impact factor: 6.961

3.  Sensitization of the trigeminovascular system following environmental irritant exposure.

Authors:  Phillip Edward Kunkler; LuJuan Zhang; Jessica Joan Pellman; Gerry Stephen Oxford; Joyce Harts Hurley
Journal:  Cephalalgia       Date:  2015-02-27       Impact factor: 6.292

Review 4.  Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.

Authors:  Paul L Durham
Journal:  Headache       Date:  2008-09       Impact factor: 5.887

5.  Lack of a role for substance P in the control of dural arterial flow.

Authors:  J Carmody; M Pawlak; K Messlinger
Journal:  Exp Brain Res       Date:  1996-10       Impact factor: 1.972

6.  Electroacupuncture of the Ophthalmic Branch of the Trigeminal Nerve: Effects on Prefrontal Cortex Blood Flow.

Authors:  Takuya Suzuki; Hideaki Waki; Kenji Imai; Tatsuya Hisajima
Journal:  Med Acupunct       Date:  2020-06-16

7.  Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat.

Authors:  K Messlinger; A Suzuki; M Pawlak; A Zehnter; R F Schmidt
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 8.  Targeting CGRP: A New Era for Migraine Treatment.

Authors:  Stephanie Wrobel Goldberg; Stephen David Silberstein
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

Review 9.  Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF.

Authors:  Rashid Giniatullin; Andrea Nistri; Elsa Fabbretti
Journal:  Mol Neurobiol       Date:  2008-05-06       Impact factor: 5.590

10.  Extreme tolerance to ammonia fumes in African naked mole-rats: animals that naturally lack neuropeptides from trigeminal chemosensory nerve fibers.

Authors:  Pamela Colleen LaVinka; Antje Brand; Victoria J Landau; David Wirtshafter; Thomas J Park
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2009-02-15       Impact factor: 1.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.